ALPINE IMMUNE SCIENCES, INC.·4

Feb 12, 1:52 PM ET

TIGER MANAGEMENT L.L.C. 4

4 · ALPINE IMMUNE SCIENCES, INC. · Filed Feb 12, 2019

Insider Transaction Report

Form 4
Period: 2019-02-08
Transactions
  • Sale

    Common Stock

    2019-02-08$5.85/sh25,000$146,245137,728 total(indirect: See Footnote)
Footnotes (1)
  • [F1]The securities are held in the account of Tiger Partners Trading LLC which is wholly owned by Tiger Partners, L.P. and may be deemed to be beneficially owned by (a) Tiger Management L.L.C., the investment manager of Tiger Partners, L.P., and (b) Tiger Partners GP, LLC, the general partner of Tiger Partners, L.P. Each of Tiger Partners, L.P., Tiger Management L.L.C. and Tiger Partners GP, LLC disclaims beneficial ownership of these reported securities except to the extent of its pecuniary interest therein and affirmatively disclaims being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

Documents

1 file
  • 4
    ownership.xmlPrimary